Obesity –As Adiposity-Based Chronic Disease

At Central Gastro, we approach what has traditionally been called obesity through the lens of modern science — recognizing it as a chronic metabolic disease driven by excess, dysfunctional adipose (fat) tissue. This concept, described as Adiposity-Based Chronic Disease (ABCD), shifts the focus from weight alone to the health impact of fat distribution, function, and complications

🔎 Understanding ABCD – Beyond “Weight”

Rather than relying solely on weight or Body Mass Index (BMI), the ABCD framework considers the amount, distribution, and function of body fat, and its effect on metabolic health and organ function. Excess adipose tissue can:

✔ Release hormones and inflammatory substances that disrupt metabolism
✔ Increase insulin resistance
✔ Drive chronic low-grade inflammation
✔ Contribute to diseases like type 2 diabetes, heart disease, and liver dysfunction including MASLD (fatty liver disease)
✔ Impair cardiovascular, renal and overall health and quality of life 

This model helps clinicians identify people at risk even when traditional metrics like BMI fall short and places the emphasis on treating the disease and its complications rather than focusing on weight alone

🧠 Causes & Contributing Factors

ABCD develops from a complex interplay of genetic, biological, behavioral, and environmental factors, including:

• Genetics that influence how fat is stored and regulated
• Hormonal and metabolic imbalances that affect appetite and energy handling
• Fat distribution patterns, especially around the abdomen (visceral fat linked to higher risk)
• Lifestyle and environmental influences such as diet, physical activity, stress, sleep, and socioeconomic factors
  All of these combine to influence adipose tissue behavior and its impact on whole-body health

🩺 Health Consequences of ABCD

ABCD is a disease of dysfunction, not just size. Dysfunctional adiposity increases the risk of:

• • Metabolic conditions: Type 2 diabetes, dyslipidemia, hypertension
  • MASLD / NASH: Metabolic fatty liver disease progression
  • Cardiovascular disease (heart attack, stroke)

• Renal Diseases ( CKD)

• Certain cancers and chronic inflammation
• Sleep apnea and musculoskeletal disorders
  because adipose tissue itself acts as an active endocrine organ influencing whole-body metabolism

📈 Diagnosis — A Personalized, Holistic Approach

Rather than relying purely on BMI, the ABCD framework emphasizes:

✔ Anthropometric assessments: waist circumference, waist-to-height ratio
✔ Clinical evaluation of metabolic dysfunction (blood sugar, lipid profile, blood pressure, liver function)
✔ Assessment of fat distribution and adipose tissue function
This helps identify clinical ABCD (disease present) versus preclinical ABCD (risk is present but complications have not yet developed)

💪 Multimodal Treatment & Management

Because ABCD is a chronic, relapsing disease, long-term management is key:

🥗 Lifestyle Therapy

• Nutritional counseling
• Regular physical activity
• Behavioral support for sustainable habits

💊 Medications

• Advanced therapies, especially GLP-1 receptor agonists, can improve metabolism, promote weight reduction, and target underlying pathophysiology rather than focusing solely on weight loss.

🩺 Endoscopic & Surgical Interventions

• Where appropriate, procedures like Endoscopic Sleeve Gastroplasty (ESG) or bariatric surgery may offer additional metabolic benefits beyond simple weight reduction.

📊 Comprehensive Monitoring

• Regular follow-up with metabolic panels, liver assessment, and cardiovascular risk evaluation

📌 Central Gastro’s Holistic ABCD Care

At Central Gastro, we personalize your care based on your metabolic health — not just a number on a scale. Our approach includes:

✔ Thorough metabolic and adiposity assessment
✔ Individualized treatment plans integrating lifestyle, medication, and procedural options
✔ Support for associated liver and GI conditions such as fatty liver disease and metabolic syndrome
✔ Long-term follow-up and support for sustainable health

🙋‍♂️ Take Action Toward Better Metabolic Health

Adiposity-Based Chronic Disease is neither a flaw nor a failure — it is a recognized medical condition that deserves expert care, empathy, and evidence-based treatment. Early assessment and tailored management can dramatically reduce your health risks and improve quality of life.